𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A

✍ Scribed by Thomas M. Polasek; Janani S. Sadagopal; David J. Elliot; John O. Miners

Publisher
Springer
Year
2009
Tongue
English
Weight
211 KB
Volume
66
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

In Vitro/in Vivo scaling of alprazolam m
In Vitro/in Vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans
✍ Noriko Hirota; Kiyomi Ito; Takafumi Iwatsubo; Carol E. Green; Charles A. Tyson; πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 243 KB πŸ‘ 1 views

We attempted to predict the in vivo metabolic clearance of alprazolam from in vitro metabolic studies using human liver microsomes and human CYP recombinants. Good correlations were observed between the intrinsic clearance (CL int ) for 4-hydroxylation and CYP3A4 content and between the CL int for a

Species differences in in vitro and in v
Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates
✍ Hiroshi Komura; Masahiro Iwaki πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

Intestinal first-pass metabolism has a great impact on the bioavailability of CYP3A substrates in humans, and the in vivo impact has quantitatively been evaluated using CYP3A inhibitors or inducers. In vitro and in vivo preclinical investigations for intestinal metabolism are essential in clarifying